Skip to content

Clinical trials

Phase 2 Lung Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2 Country / region: Russia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20102
20111
20121
20131
20141
20151
20161
20172
20182
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Active, not recruiting2
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Incyte Corporation2
Novartis Pharmaceuticals2
Peregrine Pharmaceuticals2
Apollomics Inc.1
BIND Therapeutics1
Bristol-Myers Squibb1
CSL Behring1
Eli Lilly and Company1
ImmunoGenesis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms18
Carcinoma, Non-Small-Cell Lung14
Neoplasms5
Lung Diseases3
Respiratory Tract Diseases3
Respiratory Tract Neoplasms3
Thoracic Neoplasms3
Adenocarcinoma of Lung2
Bronchial Neoplasms2
Carcinoma, Bronchogenic2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.